Multiple animal models and clinical trials have shown that blocking IL-1-induced signal transduction with the IL-1R antagonist anakinra protected mice from weight loss, fever, and CRS-related death [25]. This evidence concerns the gene IL1R1 and congenital rubella syndrome.